The "triple-witching hour" is the one before the market closes on that day (from 2 to 3 p.m. Central time), and it's when the stock market is likely to be more volatile than usual as traders buy and sell various securities before the final bell. Most options and futures represent contracts based on short-term pricing rather than long-term growth. If you're interested in a company developing cutting-edge treatments for cancer and inflammatory diseases, consider fast-growing Celgene (Nasdaq: CELG), with a market value recently topping $100 billion. Celgene sports the blockbuster cancer drug Revlimid, and its ability to continually expand Revlimid's label for new indications, such as newly diagnosed multiple myeloma, has boosted its earnings and revenue. The net result of "growth by label expansion" has been soaring sales volumes. Better still, Celgene has a deep pipeline of drugs in development and isn't threatened by looming patent expirations, as most of its best-selling drugs appear to be protected well into the 2020s.
Similar Stories to The Motley Fool: The Seasons Of The Triple Witch on Bing News
By The Motley Fool, Houston Chronicle: Business
Tue, 08/25/2015 - 8:18pm
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more